First Recreational Cannabis Dispensary Opens on Long Island
Long Island opened up its first recreational dispensary.
Recently, Long Island welcomed its first cannabis dispensary targeted for recreational use. The stores’ location is in East Farmingdale and is called “Strain Stars” (1).
It is a family-owned business and becomes the 19th cannabis dispensary to open its doors in New York. The Empire State legalized recreational cannabis in 2021 but surprisingly, only 4 towns on Long Island have accepted to permit retail stores.
New York State has given priority for licenses to individuals with a prior cannabis conviction or to their relatives.
Reference
- Long Island’s First Recreational Marijuana Dispensary Opens Up in East Farmingdale https://abc7ny.com/long-island-marijuana-dispensary-ny-dispensaries/13479278/ (accessed Jul 11, 2023).
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
